Consensus EPS · Q2 2026
$3.49
Consensus revenue · Q2 2026
$6.6B
Analysts
15
Expected report
Jul 30, 2026
What to watch
- Analyst ratings: Upgrades trending
Analyst consensus
Based on estimates from 15 analysts.
| Metric | Low | Consensus | High |
|---|---|---|---|
| Revenue | $6.5B | $6.6B | $6.8B |
| EPS | $3.36 | $3.49 | $3.61 |
| EBITDA | $1.5B | $1.5B | $1.5B |
| EBIT | $1.2B | $1.2B | $1.2B |
| Net income | $1.3B | $1.3B | $1.4B |
- Revenue$6.6B
- EPS$3.49
- EBITDA$1.5B
- EBIT$1.2B
- Net income$1.3B
Historical beat/miss
Actual reported results vs. analyst consensus at the time. Positive = beat, negative = miss.
| Period | Rev. actual | Rev. est. | Rev. surprise | EPS actual | EPS est. | EPS surprise |
|---|---|---|---|---|---|---|
| Q1 2026 | $6B | $6.3B | -5.0% | $2.60 | $2.98 | -12.8% |
- Q1 2026-5.0%-12.8%
Estimate revisions
How analyst consensus estimates have changed over the past 90 days.
Revision trends appear once we have collected at least two daily snapshots for this period.
Community vs analysts
See how the TickerLeague crowd's forecast stacks up against Wall Street.
Be the first to predict
No community consensus for Stryker (SYK) Q2 2026 yet. Make a prediction to start the crowd forecast.
Analyst price target
Based on price targets from 4 analysts.
- Low
- $315.00
- Consensus
- $381.79
- Median
- $378.00
- High
- $465.00
- Current
- $309.24
- Upside
- +23.5%
Upside calculated vs most recent trading price of $309.24.
Analyst ratings
Consensus: Buy — based on 51 analyst ratings.
24-month trend
Recent analyst actions
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jul 9, 2026 | BMO Capital | upgrade | Market Perform | Outperform |
| Jul 6, 2026 | Evercore ISI Group | maintain | Outperform | Outperform |
| Jun 5, 2026 | Leerink Partners | maintain | Outperform | Outperform |
| May 4, 2026 | Truist Securities | maintain | Hold | Hold |
| May 4, 2026 | Barclays | maintain | Overweight | Overweight |
| May 1, 2026 | Wells Fargo | maintain | Overweight | Overweight |
| May 1, 2026 | Needham | maintain | Buy | Buy |
| May 1, 2026 | JP Morgan | maintain | Overweight | Overweight |
| May 1, 2026 | Evercore ISI Group | maintain | Outperform | Outperform |
| May 1, 2026 | Canaccord Genuity | maintain | Buy | Buy |
- Jul 9, 2026BMO CapitalOutperform
- Jul 6, 2026Evercore ISI GroupOutperform
- Jun 5, 2026Leerink PartnersOutperform
- May 4, 2026Truist SecuritiesHold
- May 4, 2026BarclaysOverweight
- May 1, 2026Wells FargoOverweight
- May 1, 2026NeedhamBuy
- May 1, 2026JP MorganOverweight
- May 1, 2026Evercore ISI GroupOutperform
- May 1, 2026Canaccord GenuityBuy
Frequently asked questions
Stryker (SYK) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
- Buybacks0.15% TTM
- Dividend Profile1.13% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History9 splits
How this company returns cash to shareholders — buybacks, dividends, and stock splits.